dr. ledermann on phase iii ariel3 results in ovarian cancer
Published 6 years ago • 325 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:20
dr. ledermann on rationale for ariel3 trial in ovarian cancer
-
1:02
dr. ledermann on the results of the ariel3 trial in ovarian cancer
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
1:42
phase iii results for rucaparib in ovarian cancer
-
5:04
rucaparib and ariel3 – positive results from the phase 3 trial in ovarian cancer patients
-
1:42
dr. ledermann on rucaparib maintenance in ovarian cancer
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
0:58
dr. ledermann on systemic treatment for rare gynecologic tumors
-
9:31
ariel3: rucaparib as maintenance therapy in recurrent ovarian cancer patients
-
25:59
final overall survival results from the phase 3 solo2 trial for ovarian cancer
-
1:14
dr. coleman on benefit of rucaparib in ovarian cancer
-
1:57
dr. ledermann on parp inhibitors in maintenance therapy for ovarian cancer
-
1:56
dr. maurie markman on the phase iii aurelia trial for platinum-resistant ovarian cancer
-
2:09
rucaparib maintenance for recurrent ovarian carcinoma
-
6:12
rucaparib for recurrent ovarian cancer
-
1:14
dr. ledermann on the treatment landscape for rare gynecologic cancers
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
6:51
platinum sensitivity and parp inhibition in ovarian cancer
-
6:49
platinum-sensitive relapsed ovarian cancer: rucaparib